Importance of botulinum toxin for prevention of migraine (original) (raw)

Botulinum toxin type A (BoNTA) has gained attention for its potential in preventing migraines, particularly for patients with chronic migraine. Despite mixed findings from earlier studies, emerging evidence suggests that BoNTA may yield beneficial outcomes with repeated treatments and has a favorable side effect profile, making it a viable option for managing migraines. Cost-related challenges and the need for further research to identify responsive patients remain crucial to its widespread adoption.